Luoxin Pharmaceuticals Group Stock announced that its subsidiary Shandong Luoxin Pharmaceuticals Group Co., Ltd. received the 'Drug Registration Certificate' for teglarin tablets approved by the National Medical Products Administration, with the indication of 'used in combination with appropriate antibiotics to eradicate Helicobacter pylori'.
罗欣药业：替戈拉生片新适应症获得药品注册证书
Luoxin Pharmaceuticals Group Stock: Tegretol tablets new indications obtained pharmaceutical registration certificate.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated